• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人身体中普罗哌宗和戊烷脒的异构化及尿排泄;一项初步研究。

Isomerisation and urinary excretion of proxibarbal and valofan in man; a preliminary study.

作者信息

Wittekind H H, Testa B, Balant L P

出版信息

Eur J Drug Metab Pharmacokinet. 1984 Apr-Jun;9(2):117-22. doi: 10.1007/BF03189614.

DOI:10.1007/BF03189614
PMID:6146529
Abstract

Proxibarbal and valofan are tautomeric drugs which interconvert rapidly in solution. In the present study, the urinary excretion of these two drugs was investigated in two subjects after separate oral administration. In both cases, only proxibarbal was found in urine, while the excretion of valofan was negligible or non-detectable. More than half of a dose remains unaccounted for after proxibarbal administration, and more than three quarters after valofan administration. A simple chemical equilibrium of tautomerism as found in vitro is insufficient to account for the excretion kinetics of the two drugs in humans.

摘要

普罗西巴比妥和戊双胺是互变异构药物,在溶液中能迅速相互转化。在本研究中,对两名受试者分别口服这两种药物后的尿液排泄情况进行了调查。在这两种情况下,尿液中仅发现了普罗西巴比妥,而戊双胺的排泄量可忽略不计或无法检测到。服用普罗西巴比妥后,超过一半的剂量去向不明,服用戊双胺后则超过四分之三。体外发现的简单互变异构化学平衡不足以解释这两种药物在人体中的排泄动力学。

相似文献

1
Isomerisation and urinary excretion of proxibarbal and valofan in man; a preliminary study.人身体中普罗哌宗和戊烷脒的异构化及尿排泄;一项初步研究。
Eur J Drug Metab Pharmacokinet. 1984 Apr-Jun;9(2):117-22. doi: 10.1007/BF03189614.
2
Pharmacokinetics of 14C-2-allophanyl-2-allyl -gamma-valero-lactone: a prodrug of proxibarbal in rats.14C - 2 - 脲基丙基 - 2 - 烯丙基 - γ - 戊内酯(丙戊酰胺前体药物)在大鼠体内的药代动力学
Eur J Drug Metab Pharmacokinet. 1981;6(3):161-9. doi: 10.1007/BF03189485.
3
[Development of proxibarbal blood levels. The role of various elimination processes].[普罗巴必利血药浓度的变化。各种消除过程的作用]
J Pharmacol. 1984 Apr-Jun;15(2):223-30.
4
Effects of an atypical barbiturate (valofan) on spontaneous and stimulated locomotor activity and on brain serotonin metabolism in mice.一种非典型巴比妥酸盐(瓦洛芬)对小鼠自发和刺激的运动活动以及脑血清素代谢的影响。
Farmaco Sci. 1987 Oct;42(10):755-66.
5
Effect of an atypical barbiturate, the 2-allophanyl-2-allyl-4-valerolactone (valofan), on exploratory behaviour and brain serotonin concentrations in mice.一种非典型巴比妥酸盐,即2-脲基丙基-2-烯丙基-4-戊内酯(瓦洛芬)对小鼠探索行为和脑血清素浓度的影响。
J Pharmacol. 1985 Jul-Sep;16(3):279-90.
6
The urinary excretion of enibomalum (NFN) in man after administration of anaesthetic doses.给予麻醉剂量后人体中恩尼博马伦(NFN)的尿排泄情况。
Acta Pharmacol Toxicol (Copenh). 1970;28(6):484-92. doi: 10.1111/j.1600-0773.1970.tb00574.x.
7
Effects of 2-allophanyl-2-allyl-4-valerolactone (valofan) on cerebral energy metabolism of rat in normoxia and hypobaric hypoxia.2-脲基丙基-2-烯丙基-4-戊内酯(瓦洛芬)对常氧和低压低氧大鼠脑能量代谢的影响。
In Vivo. 1987 May-Jun;1(3):147-50.
8
Plasma levels and urinary excretion of three barbituric acids after oral administration to man.
Acta Pharmacol Toxicol (Copenh). 1954;10(2):147-65. doi: 10.1111/j.1600-0773.1954.tb01332.x.
9
Metabolic investigations of proxibarbal [5-allyl-5-(2-hydroxypropyl)barbituric acid] in vitro.丙戊巴比妥[5-烯丙基-5-(2-羟丙基)巴比妥酸]的体外代谢研究。
Pharm Acta Helv. 1980;55(3):79-82.
10
The excretion of hydroxyamylobarbitone in man after oral administration of amylobarbitone and hydroxyamylobarbitone.口服异戊巴比妥和羟异戊巴比妥后人体中羟异戊巴比妥的排泄情况。
J Pharm Pharmacol. 1971 Dec;23(12):936-40. doi: 10.1111/j.2042-7158.1971.tb09896.x.

引用本文的文献

1
Passage of allophanoyl-gamma-lactones through the kidney.脲基丙二酸γ-内酯经肾脏的排泄过程。
Eur J Drug Metab Pharmacokinet. 1988 Apr-Jun;13(2):77-80. doi: 10.1007/BF03191307.

本文引用的文献

1
Metabolic investigations of proxibarbal [5-allyl-5-(2-hydroxypropyl)barbituric acid] in vitro.丙戊巴比妥[5-烯丙基-5-(2-羟丙基)巴比妥酸]的体外代谢研究。
Pharm Acta Helv. 1980;55(3):79-82.
2
[Research on the new tranquilizing agents].[新型镇静剂的研究]
Farmaco Sci. 1966 May;21(5):394-407.
3
[Remarks on reactions of new barbiturate derivatives].[关于新型巴比妥酸盐衍生物反应的论述]
Farmaco Sci. 1966 Apr;21(4):310-28.